Dr Tereza Kasaeva, Director of the World Health Organization Global TB Program, released a message on World No Tobacco Day 2019 (May 31) with a focus on tobacco and lung health. Tobacco smoking more than doubles the risk of developing TB and increases the risk of dying from respiratory failure.

WHO launches a multisectoral accountability framework to end TB as requested by the World Health Assembly and the UN General Assembly in 2018.

Today, May 15, WHO’s new Science Division launched an online resource to guide the development of new health products for which there are limited markets or incentives for research and development. An essential tool for realizing universal health coverage, the Health Product Profile Directory aims to promote  research and development for products to combat neglected diseases and threats to global health, including antimicrobial resistance and diseases with pandemic potential.

Community capacity building modules to accelerate the response to drug-resistant TB launched at WHO meeting of national TB program managers and partners in the South-East Asia region.

The High-level consultation on accelerating the development of the M72/AS01E tuberculosis vaccine candidate was convened by the World Health Organization on 5 April 2019.

The World Health Organization (WHO) Task Force to support country transition towards new recommendations for the treatment of drug-resistant TB (DR-TB), created in August 2018, invites all interested TB stakeholders to participate in a webinar hosted by the WHO Global TB Program on 22 May 2019 from 14:00 to 15:30 (Central European Summer Time).

The World Health Organization (WHO) is seeking a consultant to assist the WHO Global TB Program Secretariat of the Civil Society Task Force on TB.

International organizations unite on critical recommendations to combat drug-resistant infections and prevent staggering number of deaths each year.

24 April 2019 | Manila: The Philippines Department of Health (DOH) and the World Health Organization (WHO) jointly call for an all-out-war against tuberculosis (TB), the number one infectious killer in the country. TB claims the lives of over 70 Filipinos every day. There are also one million Filipinos who have active TB disease, the third highest global prevalence rate next to South Africa and Lesotho.

12 April 2019 | Geneva: Following the release of the 2018 WHO consolidated guidelines on the treatment of drug-resistant tuberculosis, the Western Pacific Regional Office (WPRO) of WHO through its Green Light Committee (GLC) mechanism organized a consultant training workshop held from 27-29 March 2019 in Sydney, Australia. A total of 25 experts were equipped with the necessary knowledge and skills, including practical problem-solving, diplomacy and cultural competencies to ensure delivery of high quality support and constructive communication at all levels within the TB programme and government in line with WHO standards.